Next |
home / stock / alzn / alzn message board
Subject | By | Source | When |
---|---|---|---|
Short of a cure this goes nowhere | Roozy | investorshub | 04/03/2023 4:22:48 PM |
To date, I've made almost $10K trading the | PennyStockTrader2 | investorshub | 04/01/2023 1:33:33 PM |
BFnD!! | Roozy | investorshub | 03/24/2023 12:19:17 AM |
Gotta be for sale cheap!! | Roozy | investorshub | 03/17/2023 4:14:05 PM |
NO confidence vote here!! | Roozy | investorshub | 02/24/2023 8:38:33 PM |
The End approaches | Roozy | investorshub | 02/24/2023 4:17:30 PM |
Continued to buy down to 50 cents, could | PennyStockTrader2 | investorshub | 01/04/2023 12:19:02 AM |
Oooooops to .58!!!!!!!!! | Roozy | investorshub | 12/27/2022 11:35:48 PM |
Oooooops to .6150!!!!!! | Roozy | investorshub | 12/27/2022 7:40:21 PM |
$33 birthday to .8396!!!!! Sell off for $5/share | Roozy | investorshub | 12/19/2022 1:57:05 PM |
I saw that, and I also see $ALZN | PennyStockTrader2 | investorshub | 12/15/2022 10:08:14 PM |
SEC Charges Eight Social Media Influencers in $100 | Renee | investorshub | 12/14/2022 11:48:06 PM |
Great blurb on Fox Business | Roozy | investorshub | 11/16/2022 8:00:38 PM |
no luck so far on getting new strikes | PennyStockTrader2 | investorshub | 11/03/2022 2:22:46 AM |
continue to trade a bit of $ALZN taking | PennyStockTrader2 | investorshub | 10/13/2022 10:12:07 PM |
What? 5,000,000+ shares traded | Roozy | investorshub | 09/28/2022 5:27:48 PM |
I have spoken English for 76 years Its a joke!!! | Roozy | investorshub | 09/28/2022 2:28:10 PM |
its a US english expression, it means that | PennyStockTrader2 | investorshub | 09/28/2022 2:11:07 PM |
Own what? | Roozy | investorshub | 09/28/2022 12:33:37 PM |
all things considered, ALz is holding its own. | PennyStockTrader2 | investorshub | 09/21/2022 10:37:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...
Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical compa...
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“ Alzamend ”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“ Alzheimer’s ”), bipolar disorder (“ BD ”), major de...